Skip to main content

ACIDEMIA PROPIONICA: DE LOS MODELOS Y MECANISMOS HACIA BIOMARCADORES Y TERAPIAS

SAF2016-76004-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Intracellular calcium mishandling leads to cardiac dysfunction and ventricular arrhythmias in a mouse model of propionic acidemia

  • Tamayo, María
  • Fulgencio-Covián, A.
  • Navarro-García, Jose A.
  • Val-Blasco, Almudena
  • Ruiz-Hurtado, Gema
  • Gil-Fernández, Marta
  • Martín-Nunes, Laura
  • Lopez, J. A.
  • Desviat, Lourdes R.
  • Delgado, Carmen
  • Richard, C.
  • Fernández-Velasco, María
Propionic acidemia (PA) is a rare metabolic disease associated with mutations in genes encoding the α and β subunits of the enzyme propionyl-CoA carboxylase. The accumulation of toxic metabolites results in mitochondrial dysfunction, increased reactive oxygen species production and oxidative damage, which have been associated with the disease pathophysiology. Clinical symptoms are heterogeneous and include cardiac complications, mainly cardiac dysfunction and arrhythmias, which are recognized as one of the major life-threatening manifestations in patients. We aimed to investigate the molecular mechanisms underlying the cardiac phenotype using a hypomorphic mouse model (Pcca−/−(A138T)) that recapitulates some biochemical and clinical characteristics of PA. We demonstrate that Pcca−/−(A138T) mice present with depressed cardiac function along with impaired cell contractility when compared to the wild-type mice. Cardiac dysfunction in Pcca−/−(A138T) mice was associated with lower systolic Ca2+ release ([Ca2+]i transients), impairment in the sarcoplasmic reticulum (SR) Ca2+ load and decreased Ca2+ re-uptake by SR-Ca2+ ATPase (SERCA2a). These functional changes correlated well with the depressed activity of SERCA2a, the elevated ROS levels and SERCA2a oxidation rate in cardiomyocytes isolated from Pcca−/−(A138T) mice. In addition, decreased SR-Ca2+ load in Pcca−/−(A138T) cardiomyocytes was associated with increased diastolic Ca2+ release. The increase in Ca2+ sparks, Ca2+ waves and spontaneous [Ca2+]i transients in Pcca−/−(A138T) cardiomyocytes could be responsible for the induction of ventricular arrhythmias detected in these mice. Overall, our results uncover the role of impaired Ca2+ handling in arrhythmias and cardiac dysfunction in PA, and identify new targets for the development of therapeutic approaches for this devastating metabolic disease., This work was supported by Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (SAF2016-76004-R, SAF2017-84777-R and PGC2018-097019-B-I00), Instituto de Salud Carlos III (ISCIII) (PI17/01093, PI17/01344 and IPT17/0019 - ISCIII-SGEFI/ERDF, ProteoRed), European Regional Development Fund (FEDER), FSE, the Fundació Marató TV3 (grant 122/C/2015) and CIBERER and CIBER-CV, networks funded by ISCIII. Centro de Biología Molecular Severo Ochoa receives an institutional grant from Fundación Ramón Areces. The CNIC is supported by ISCIII, Spanish Ministry of Science, Innovation and Universities (MCIU) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). MF-V is Miguel Servet II researcher of ISCIII (MSII16/00047 Carlos III Health Institute). GR-H is Miguel Servet I researcher of ISCIII (CP15/00129 Carlos III Health Institute). MT is a PhD student funded by the FPU program of MCIU (FPU17/06135). AFC is a PhD student funded by the FPI-UAM program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic Acidemia

  • Alonso-Barroso, Esmeralda
  • Pérez, Belén
  • Ruiz Desviat, Lourdes
  • Richard, Eva
© 2021 by the authors, Propionic acidemia (PA), one of the most frequent life-threatening organic acidemias, is caused by mutations in either the PCCA or PCCB genes encoding both subunits of the mitochondrial propionyl-CoA carboxylase (PCC) enzyme. Cardiac alterations (hypertrophy, dilated cardiomyopathy, long QT) are one of the major causes of mortality in patients surviving the neonatal period. To overcome limitations of current cellular models of PA, we generated induced pluripotent stem cells (iPSCs) from a PA patient with defects in the PCCA gene, and successfully differentiated them into cardiomyocytes. PCCA iPSC-derived cardiomyocytes exhibited reduced oxygen consumption, an accumulation of residual bodies and lipid droplets, and increased ribosomal biogenesis. Furthermore, we found increased protein levels of HERP, GRP78, GRP75, SIG-1R and MFN2, suggesting endoplasmic reticulum stress and calcium perturbations in these cells. We also analyzed a series of heart-enriched miRNAs previously found deregulated in the heart tissue of a PA murine model and confirmed their altered expression. Our novel results show that PA iPSC-cardiomyocytes represent a promising model for investigating the pathological mechanisms underlying PA cardiomyopathies, also serving as an ex vivo platform for therapeutic evaluation., Research reported in this work was funded by Grant PAF107 from the Propionic Acidemia Foundation; SAF2016-76004-R from Spanish Ministry of Economy, Industry and Competitiveness— Agencia Estatal de Investigación and European Regional Development Fund (Fondos Feder); PID2019- 105344RB-I00/AEI/10.13039/501100011033 from Spanish Ministry of Science and Innovation and by LCF/PR/PR16/11110018 from Fundación Isabel Gemio, Fundación La Caixa., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of 34 novel mutations in propionic acidemia: Functional characterization of missense variants and phenotype associations

  • Rivera-Barahona, Ana
  • Navarrete, Rosa
  • García-Rodríguez, Raquel
  • Richard, Eva
  • Ugarte, Magdalena
  • Pérez-Cerdá, Celia
  • Pérez, Belén
  • Gámez, Alejandra
  • Desviat, Lourdes R.
Propionic acidemia (PA) is caused by mutations in the PCCA and PCCB genes, encoding α and β subunits, respectively, of the mitochondrial enzyme propionyl-CoA carboxylase (PCC). Up to date, >200 pathogenic mutations have been identified, mostly missense defects. Genetic analysis in PA patients referred to the laboratory for the past 15 years identified 20 novel variants in the PCCA gene and 14 in the PCCB gene. 21 missense variants were predicted as probably disease-causing by different bioinformatics algorithms. Structural analysis in the available 3D model of the PCC enzyme indicated potential instability for most of them. Functional analysis in a eukaryotic system confirmed the pathogenic effect for the missense variants and for one amino acid deletion, as they all exhibited reduced or null PCC activity and protein levels compared to wild-type constructs. PCCB variants p.E168del, p.Q58P and p.I460T resulted in medium-high protein levels and no activity. Variants p.R230C and p.C712S in PCCA, and p.G188A, p.R272W and p.H534R in PCCB retained both partial PCC activity and medium-high protein levels. Available patients-derived fibroblasts carriers of some of these mutations were grown at 28 °C or 37 °C and a slight increase in PCC activity or protein could be detected in some cases at the folding-permissive conditions. Examination of available clinical data showed correlation of the results of the functional analysis with disease severity for most mutations, with some notable exceptions, confirming the notion that the final phenotypic outcome in PA is not easily predicted., This work was supported by Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (grant number SAF2016-76004-R). Centro de Biología Molecular Severo Ochoa receives an institutional grant from Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology

  • Fulgencio-Covián, Alejandro
  • Álvarez, Mar
  • Pepers, Barry A.
  • López-Márquez, Arístides
  • Ugarte, Magdalena
  • Pérez, Belén
  • van Roon-Mom, Willeke M.C.
  • Desviat, Lourdes R.
  • Richard, Eva
Propionic acidemia (PA) is an inherited metabolic disease caused by mutations in the PCCA and PCCB genes. We have previously generated an induced pluripotent stem cell (iPSC) line (UAMi004-A) from a PA patient with the c.1218_1231del14ins12 (p.Gly407Argfs*14) homozygous mutation in the PCCB gene. Here, we report the generation of the isogenic control in which the mutation was genetically corrected using CRISPR/Cas9 technology. Off-target editing presence was excluded and the iPSCs had typical embryonic stem cell-like morphology and normal karyotype that expressed pluripotency markers and maintained their in vitro differentiation potential., Research reported in this work was funded by Grant PAF107 from the Propionic Acidemia Foundation and by grants SAF2016-76004-R from Spanish Ministry of Economy, Industry and Competitiveness - Agencia Estatal de Investigación and European Regional Development Fund (Fondos Feder) and PID2019-105344RB-I00/AEI/10.13039/501100011033 from Spanish Ministry of Science and Innovation. The authors thank Federación Española de Enfermedades Metabólicas Hereditarias and the patients’ families for their collaboration and for agreeing to participate in the study, the Cytogenetic unit from Centro Nacional de Investigaciones Oncológicas (CNIO) and Elena Montalvo for their excellent technical assistance. Centro de Biología Molecular Severo Ochoa receives an institutional grant from Fundación Ramón Areces. AFC is a PhD student funded by the FPI-UAM program.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology

  • Fulgencio-Covián, Alejandro
  • Álvarez, Mar
  • Pepers, Barry A.
  • López-Márquez, Arístides
  • Ugarte, Magdalena
  • Pérez, Belén
  • van Roon-Mom, Willeke M.C.
  • Desviat, Lourdes R.
  • Richard, Eva
Propionic acidemia (PA) is an inherited metabolic disease caused by mutations in the PCCA and PCCB genes. We have previously generated an induced pluripotent stem cell (iPSC) line (UAMi004-A) from a PA patient with the c.1218_1231del14ins12 (p.Gly407Argfs*14) homozygous mutation in the PCCB gene. Here, we report the generation of the isogenic control in which the mutation was genetically corrected using CRISPR/Cas9 technology. Off-target editing presence was excluded and the iPSCs had typical embryonic stem cell-like morphology and normal karyotype that expressed pluripotency markers and maintained their in vitro differentiation potential., Research reported in this work was funded by Grant PAF107 from the Propionic Acidemia Foundation and by grants SAF2016-76004-R from Spanish Ministry of Economy, Industry and Competitiveness - Agencia Estatal de Investigación and European Regional Development Fund (Fondos Feder) and PID2019-105344RB-I00/AEI/10.13039/501100011033 from Spanish Ministry of Science and Innovation. The authors thank Federación Española de Enfermedades Metabólicas Hereditarias and the patients’ families for their collaboration and for agreeing to participate in the study, the Cytogenetic unit from Centro Nacional de Investigaciones Oncológicas (CNIO) and Elena Montalvo for their excellent technical assistance. Centro de Biología Molecular Severo Ochoa receives an institutional grant from Fundación Ramón Areces. AFC is a PhD student funded by the FPI-UAM program.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pathogenic implications of dysregulated miRNAs in propionic acidemia related cardiomyopathy

  • Fulgencio-Covián, Alejandro
  • Alonso-Barroso, Esmeralda
  • Guenzel, Adam J.
  • Rivera-Barahona, Ana
  • Ugarte, Magdalena
  • Pérez, Belén
  • Barry, Michael A.
  • Pérez-Cerdá, Celia
  • Richard, Eva
  • Desviat, Lourdes R.
Cardiac alterations (hypertrophic/dilated cardiomyopathy, and rhythm alterations) are one of the major causes of mortality and morbidity in propionic acidemia (PA), caused by the deficiency of the mitochondrial enzyme propionyl-CoA carboxylase (PCC), involved in the catabolism of branched-chain amino acids, cholesterol, and odd-chain fatty acids. Impaired mitochondrial oxidative phosphorylation has been documented in heart biopsies of PA patients, as well as in the hypomorphic Pcca(A138T) mouse model, in the latter correlating with increased oxidative damage and elevated expression of cardiac dysfunction biomarkers atrial and brain natriuretic peptides (ANP and BNP) and beta-myosin heavy chain (β-MHC). Here we characterize the cardiac phenotype in the PA mouse model by histological and echocardiography studies and identify a series of upregulated cardiac-enriched microRNAs (miRNAs) in the PA mouse heart, some of them also altered as circulating miRNAs in PA patients’ plasma samples. In PA mice hearts, we show alterations in signaling pathways regulated by the identified miRNAs, which could be contributing to cardiac remodeling and dysfunction; notably, an activation of the mammalian target of rapamycin (mTOR) pathway and a decrease in autophagy, which are reverted by rapamycin treatment. In vitro studies in HL-1 cardiomyocytes indicate that propionate, the major toxic metabolite accumulating in the disease, triggers the increase in expression levels of miRNAs, BNP, and β-MHC, concomitant with an increase in reactive oxygen species. Our results highlight miRNAs and signaling alterations in the PCC-deficient heart which may contribute to the development of PA-associated cardiomyopathy and provide a basis to identify new targets for therapeutic intervention., The technical assistance of Elena Montalvo and the expert advice of the staff at CNIC Imaging Facility are gratefully acknowledged. The authors thank Federación Española de Enfermedades Metabólicas Hereditarias and the patients’ families for their collaboration and for agreeing to participate in the study. This work was supported by Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (grant number SAF2016-76004-R) and by Fundación Isabel Gemio and Fundación La Caixa (LCF/PR/PR16/11110018). AFG is funded by the FPI-UAM program, EAB and ARB by the Spanish Ministry of Science, Innovation and Universities (predoctoral fellowships FPU15/02923 and BES-2014-069420, respectively). Centro de Biología Molecular Severo Ochoa receives an institutional grant from Fundación Ramón Areces.